Ajanta Pharma has posted a 3.41% increase in its consolidated net profit at Rs.147.47 crore for the December quarter. Last year, in the corresponding quarter...
On Thursday, Ajanta Pharma has launched eletriptan hydrobromide tablets which is used in treating headaches in the US market. Ajanta Pharma has said in a...
The US health regulator has provided its approval to the Ajanta Pharma for generic Omeprazole and sodium bicarbonate powder for oral suspension used to treat...
Ajanta Pharma has launched generic omeprazole and sodium bicarbonate capsules that are used in the treatment acid reflux and uclers, in the US market after...
Ajanta Pharma has launched anti-dementia Memantine Hydrochloride tablets in the US market. The company has announced in BSE filing ” the launch of Memantine Hydrochloride...
The US health regulator has given its final approval to Ajanta Pharma for the generic version of its acute migraine pain relief drug Zolmitriptan tablets....